

Drug Class: | Aromatase Inhibitor |
Pharmaceutical Name: | Letro-Lab |
Chemical Name: | Letrozole |
Chemical Abstract Name: | 4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile |
Molecular Structure: | C17H11N5 |
Molecular Weight: | 285.303 g/mol |
Active Half Life: | 2 Days |
Dosage: | 0.5-2.5 mg/day |
Acne: | No |
Water retention: | No |
High blood pressure: | No |
Hepatotoxicity: | No |
Aromatization: | No |
Hypothalamus-Pituitary-Testes-Axis suppression: | None |
Manufacturer: | 7Lab Pharma |
Country: | Switzerland |
Presentation: | Letro-Lab for sale - 1 x 50 tabs х 2.5 mg |
Commercial Names: Letromina, Letroxyl, Letoripe, Fempro, Mamazol, Femara, Letocor, Feofer, Momazol, Oreta, Letoval, Letz, Letrazole, Zaronil, Letzol, Fematroz, Shantroz, Lets, Letrozol, Letroz, Letronat, Oncolet, Feofar, Letros, Letrova, Trozet.
Please log in to write Letro-Lab review.